<DOC>
	<DOCNO>NCT01444183</DOCNO>
	<brief_summary>The study examine whether stress reduction intervention reduces number seizures people drug resistant epilepsy . In proposed randomized control , double blind trial , investigator enroll subject frequent seizure , especially identify stress seizure precipitant . There observational phase ( 8-12 week ) treatment phase ( 12 week ) . During observational phase , subject monitor multiple time daily via smart phone device , order identify high risk day seizure . In treatment phase , subject randomly assign one two group receive different focused attention practice . These behavioral intervention administer daily extra intervention apply day high risk .</brief_summary>
	<brief_title>Stress Management Intervention Living With Epilepsy ( SMILE )</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Age 18 year English speak Partial epilepsy consistent ILAE criterion support either EEG MRI data Experiencing least 2 seizures/month Reported awareness seizure , include seizure cluster One following : 1 . Patientreported ability selfpredict seizures 2 . Patientreported awareness trigger factor , include stress 3 . Patientreported awareness premonitory feature Able maintain accurate ediary independently Minimum 6th grade read level screen WRAT administration Must stable dose antiepileptic drug least 30 day prior study entry May stable dose SSRI , SNRI , atypical antipsychotic least 6 month May stable dose benzodiazepine ( , dose stable least 30 day prior study entry ) For inclusion clinical trial phase , patient must be/have : A minimum 4 seizure document 8week baseline phase ( 6 seizure 12week extended baseline phase ) At least 1 seizure per 4week period two three 4week period extend baseline phase Diaries satisfactorily complete baseline phase Complied study requirement baseline phase Nonmotor simple partial seizure Concurrent VNS use History suicide attempt within past 2 year Current suicidality Not competent sign consent Status epilepticus within previous 6 month Began regularly use behavioral technique stress reduction within past 3 month Did benefit adequate trial valid stress reduction technique Progressive neurologic condition investigator believe would affect seizure frequency Any history substance abuse within previous 2 year History poor medication compliance judge investigator Psychiatric illness require change medication dose Any medical psychiatric condition would impair reliable participation trial Intermittent use benzodiazepine ( used sleep , determine case case )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>seizure</keyword>
	<keyword>stress reduction</keyword>
</DOC>